Exogenous glycosaminoglycans coat damaged bladder surfaces in experimentally damaged mouse bladder

BMC Urology

Volumn 5, Issue , 2005, Pages

  Kyker, Kimberly D ^a   Coffman, Jean ^a   Hurst, Robert E ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; FLUORESCENT DYE; GLYCOSAMINOGLYCAN; HYDROCHLORIC ACID; PROTAMINE SULFATE; TRYPSIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER INJURY; BLADDER MUSCLE; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; FROZEN SECTION; HISTOPATHOLOGY; INTERSTITIAL CYSTITIS; MATERIAL COATING; MOUSE; NONHUMAN; SURFACE PROPERTY;

ANIMALS; CHONDROITIN SULFATES; CYSTITIS, INTERSTITIAL; FLUORESCENT DYES; GLYCOSAMINOGLYCANS; MICE; MICE, INBRED C57BL; URINARY BLADDER; XANTHENES;

EID: 18044366748     PISSN: 14712490     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-5-4     Document Type: Article

References (27)

1. Lukban JC, Parkin JV, Holzberg AS, Caraballo R, Kellogg-Spadt S, Whitmore KE: Interstitial cystitis and pelvic floor dysfunction: a comprehensive review. Pain Med 2001, 2:60-71.
2. Sand PK: Chronic pain syndromes of gynecologic origin. J Reprod Med 2004, 49:230-234.
3. Messing EM, Stamey TA: Interstitial cystitis: early diagnosis, pathology, and treatment. Urology 1978, 12:381-392.
4. Elbadawi AE, Light JK: Distinctive ultrastructural pathology of nonulcerative interstitial cystitis: new observations and their potential significance in pathogenesis. Urol Int 1996, 56:137-162.
5. Keay SK, Szekely Z, Conrads TP, Veenstra TD, Barchi JJJ, Zhang CO, Koch KR, Michejda CJ: An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. Proc Natl Acad Sci U S A 2004, 101:11803-11808.
6. Slobodov G, Feloney M, Gran C, Kyker KD, Hurst RE, Culkin DJ: Abnormal Expression of Molecular Markers for Bladder Impermeability and Differentiation in Urothelium of Interstitial Cystitis Patients. J Urol 2004, 171:1554-1558.
7. Hurst RE, Roy JB, Min KW, Veltri RW, Marley G, Patton K, Shackelford, DL, Stein P, Parsons CL: A deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitis. Urology 1996, 48:817-821.
8. Grist M, Chakraborty J: Identification of a mucin layer in the urinary bladder. Urology 1994, 44:26-33.
9. Hurst RE, Zebrowski R: Identification of proteoglycans present at high density on bovine and human bladder luminal surface. J Urol 1994, 152:1641-1645.
10. Nickel JC, Cornish J: Ultrastructural study of an antibody-stabilized bladder surface: a new perspective on the elusive glycosaminoglycan layer. World J Urol 1994, 12:11-14.
11. Hurst RE, Rhodes SW, Adamson PB, Parsons CL, Roy JB: Functional and structural characteristics of the glycosaminoglycans of the bladder luminal surface. J Urol 1987, 138:433-437.
12. Parsons CL, Forrest J, Nickel JC, Evans R, Lloyd LK, Barkin J, Mosbaugh PG, Kaufman DM, Hernandez-Graulau JM, Atkinson L, Albrecht D: Effect of pentosan polysulfate therapy on intravesical potassium sensitivity. Urology 2002, 59:329-333.
13. Parsons CL, Greenspan C, Moore SW, Mulholland SG: Role of surface mucin in primary antibacterial defense of bladder. Urology 1977, 9:48-52.
14. Lewis SA, Berg JR, Kleine TJ: Modulation of epithelial permeability by extracellular macromolecules. Physiol Rev 1995, 75:561-589.
15. Negrete HO, Lavelle JP, Berg J, Lewis SA, Zeidel ML: Permeability properties of the intact mammalian bladder epithelium. Am J Physiol 1996, 271:F886-F894.
16. Bade JJ, Laseur M, Nieuwenburg A, Van der Weele LT, Mensink HJA: A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis. Br J Urol 1997, 79:168-171.
17. Nordling J, Jorgensen S, Kallestrup E: Cystistat for the treatment of interstitial cystitis: a 3-year follow-up study. Urology 2001, 57:123.
18. Steinhoff G, Ittah B, Rowan S: The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. Can J Urol 2002, 9:1454-1458.
19. Parsons CL, Housley T, Schmidt JD, Lebow D: Treatment of interstitial cystitis with intravesical heparin. Br J Urol 1994, 73:504-507.
20. Hurst RE, Roy JB, Parsons CL: The role of glycosaminoglycans in normal bladder physiology and the pathophysiology of interstitial cystitis. In Interstitial Cystitis Edited by: Sant GR. Philadelphia, Lippincott-Raven; 1997:93-100.
21. Tzan CJ, Berg J, Lewis SA: Effect of protamine sulfate on the permeability properties of the mammalian urinary bladder. J Membr Biol 1993, 133:227-242.
22. Giedrojc J, Klimiuk M, Radziwon P, Kloczko J, Bielawiec M, Breddin HK: Comparative study on the in vitro and in vivo activities of heparinoids derivative investigated on the animal model. J Cardiovasc Pharmacol 1999, 34:340-345.
23. Brecher AS, Adamu MT: Coagulation protein function: enhancement of the anticoagulant effect of acetaldehyde by sulfated glycosaminoglycans. Dig Dis Sci 2001, 46:2033-2042.
24. Boucher WS, Letourneau R, Huang M, Kempuraj D, Green M, Sant GR, Theoharides TC: Intravesical sodium hyaluronate inhibits the rat urinary mast cell mediator increase triggered by acute immobilization stress. J Urol 2002, 167:380-384.
25. Chiang G, Patra P, Letourneau R, Jeudy S, Boucher W, Green M, Sant GR, Theoharides TC: Pentosanpolysulfate inhibits mast cell histamine secretion and intracellular calcium ion levels: an alternative explanation of its beneficial effect in interstitial cystitis. J Urol 2000, 164:2119-2125.
26. Theoharides TC, Patra P, Boucher W, Letourneau R, Kempuraj D, Chiang G, Jeudy S, Hesse L, Athanasiou A: Chondroitin sulphate inhibits connective tissue mast cells. Br J Pharmacol 2000, 131:1039-1049.
27. Lewis SA, Clausen C: Urinary proteases degrade epithelial sodium channels. J Membr Biol 1991, 122:77-88.